This patent appears to be a composition of matter patent on various histone deacetylases. These proteins, histone deacetylases, are very important in controlling gene expression. Typically histone deacetylases suppress gene expression by deacetylazing histones, which control large parts of the DNA. Since histone deacetylase inhibitors actually stimulate expression of genes that are normally turn off, the transfection of histone deacetylases should be useful for turning off genes that should be turned on.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.